Model Predictive Control of Erythropoietin Administration in the Anemia of ESRD

American Journal of Kidney Diseases

Volumn 51, Issue 1, 2008, Pages 71-79

  Gaweda, Adam E ^a   Jacobs, Alfred A ^a   Aronoff, George R ^a   Brier, Michael E ^a,b  

^a University of Louisville School of Medicine   (United States)

^b DEPARTMENT OF VETERANS AFFAIRS   (United States)

Author keywords

dosing; Erythropoietin; hemoglobin

Indexed keywords

ERYTHROPOIETIN; HEMOGLOBIN; IRON; RECOMBINANT ERYTHROPOIETIN;

ADULT; AGED; ALGORITHM; ANEMIA; ARTICLE; ARTIFICIAL NEURAL NETWORK; CLINICAL PROTOCOL; COMPUTER SIMULATION; CONTROLLED STUDY; FEMALE; HEMODIALYSIS PATIENT; HEMOGLOBIN BLOOD LEVEL; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PREDICTION; PREDICTOR VARIABLE; RANDOM SAMPLE; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

AGED; ALGORITHMS; ANEMIA; COMPUTER SIMULATION; ERYTHROPOIETIN, RECOMBINANT; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NEURAL NETWORKS (COMPUTER); PREDICTIVE VALUE OF TESTS; TREATMENT OUTCOME;

EID: 37349025512     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2007.10.003     Document Type: Article

References (13)

1. National Kidney Foundation. NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: Update 2000. Am J Kidney Dis 37 suppl 1 (2001) S182-S238
2. National Kidney Foundation. NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: Update 2000. Am J Kidney Dis 47 suppl 3 (2006) S33-S53
3. Singh A.K., Szczech L., Tang K.L., et al. Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 355 (2006) 2085-2098
4. Lacson E., Ofsthun N., and Lazarus J.M. Effect of variability in anemia management on hemoglobin outcomes in ESRD. Am J Kidney Dis 41 (2003) 111-124
5. Gaweda A.E., Jacobs A.A., Brier M.E., and Zurada J.M. Pharmacodynamic population analysis in chronic renal failure using artificial neural networks-A comparative study. Neural Networks 16 (2003) 841-845
6. Drüke T.B., Locatelli F., Clyne N., et al. Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med 355 (2006) 2071-2084
7. Besarab A., Bolton W.K., Browne J.K., et al. The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med 339 (1998) 584-590
8. Brimble K.S., Rabbat C.G., McKenna P., Lambert K., and Carlisle E.J. Protocolized anemia management with erythropoietin in hemodialysis patients: A randomized controlled trial. J Am Soc Nephrol 14 (2003) 2654-2661
9. Tolman C., Richardson D., Bartlett C., and Will E. Structured conversion from thrice weekly to weekly erythropoietic regimens using a computerized decision-support system: A randomized clinical study. J Am Soc Nephrol 16 (2005) 1463-1470
10. Gaweda A.E., Muezzinoglu M.K., Aronoff G.R., Jacobs A.A., Zurada J.M., and Brier M.E. Individualization of pharmacological anemia management using reinforcement learning. Neural Networks 18 (2005) 826-834
11. Martin-Guerrero J.D., Camps-Valls G., Soria-Olivas E., Serrano-Lopez A.J., Perez-Ruixo J.J., and Jimenez-Torres N.V. Dosage individualization of erythropoietin using a profile-dependent support vector regression. IEEE Trans Biomed Eng 50 (2003) 1136-1142
12. Martin Guerrero J.D., Olivas E.S., Valls G.C., Serrano Lopez A.J., Perez Ruixo J.J., and Torres N.V. Use of neural networks for dosage individualization of erythropoietin in patients with secondary anemia to chronic renal failure. Comput Biol Med 33 (2003) 361-373
13. Bellazzi R. Drug delivery optimization through Bayesian networks: An application to erythropoietin therapy in uremic anemia. Comp Biomed Res 26 (1993) 274-293